SCHEMBL10073119

SCHEMBL10073119

COc1ccc(CCN(C)C(=O)c2cccnc2Oc2ccccc2)cc1OC

nearest known ligand 0.57

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.57
NPC1 O15118 2/20 0.53
MAPK8 P45983 1/20 0.51
KMT2A Q03164 2/20 0.49
TDP1 Q9NUW8 1/20 0.49
ALDH1A1 P00352 3/20 0.48
KDM4E B2RXH2 1/20 0.48
MEN1 O00255 1/20 0.48
CYP3A4 P08684 1/20 0.48
GAA P10253 1/20 0.48
MAPT P10636 1/20 0.48
LMNA P02545 1/20 0.47
RAB9A P51151 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10073079 0.90 POLB (0.64) POLBNPC1KMT2AALDH1A1KDM4E
SCHEMBL10073084 0.87 POLB (0.76) POLBNPC1KMT2AALDH1A1KDM4E
SCHEMBL10073061 0.86 POLB (0.65) POLBNPC1KMT2AALDH1A1KDM4E
SCHEMBL10073069 0.85 POLB (0.64) POLBNPC1KMT2AALDH1A1MEN1
SCHEMBL10073082 0.85 POLB (0.58) POLBNPC1KMT2AALDH1A1KDM4E
SCHEMBL10073081 0.84 POLB (0.60) POLBNPC1KMT2AALDH1A1KDM4E
SCHEMBL557635 0.83 POLB (0.59) POLBNPC1KMT2AALDH1A1KDM4E
SCHEMBL10073080 0.82 POLB (0.55) POLBNPC1KMT2AALDH1A1KDM4E
SCHEMBL10073121 0.81 MAPK8 (0.64) MAPK8ALDH1A1GAAMAPTLMNA
SCHEMBL1586895 0.76 NPC1 (0.62) NPC1KMT2AMEN1CYP3A4GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130012536-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-01-10 US disclosed
US-20130012536-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-01-10 US disclosed
US-20120035179-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMACEUTICALS INCORPORATED 2012-02-09 US disclosed
US-20120035179-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMACEUTICALS INCORPORATED 2012-02-09 US disclosed
US-20100125090-A1 Modulators of ATP-Binding Cassette Transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-05-20 US disclosed
US-20100125090-A1 Modulators of ATP-Binding Cassette Transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-05-20 US disclosed
US-7598412-B2 Modulators of ATP-binding cassette transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2009-10-06 US disclosed
US-7598412-B2 Modulators of ATP-binding cassette transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2009-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130012536-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS ABCB11, ABCB1, ABCC5 POLB 1098/4885NPC1 36/4885MAPK8 4045/4885
US-20100125090-A1 Modulators of ATP-Binding Cassette Transporters ABCB11, ABCB1, ABCC5 POLB 1098/4885NPC1 36/4885MAPK8 4045/4885
US-20120035179-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS ABCB11, ABCB1, ABCC5 POLB 1098/4885NPC1 36/4885MAPK8 4045/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.